Annual Retained Earnings
-$310.00 M
-$68.96 M-28.61%
December 31, 2023
Summary
- As of February 8, 2025, PMVP annual retained earnings is -$310.00 million, with the most recent change of -$68.96 million (-28.61%) on December 31, 2023.
- During the last 3 years, PMVP annual retained earnings has fallen by -$200.12 million (-182.13%).
- PMVP annual retained earnings is now -518.92% below its all-time high of -$50.09 million, reached on December 31, 2018.
Performance
PMVP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$345.71 M
-$19.23 M-5.89%
September 30, 2024
Summary
- As of February 8, 2025, PMVP quarterly retained earnings is -$345.71 million, with the most recent change of -$19.23 million (-5.89%) on September 30, 2024.
- Over the past year, PMVP quarterly retained earnings has dropped by -$51.47 million (-17.49%).
- PMVP quarterly retained earnings is now -358.26% below its all-time high of -$75.44 million, reached on December 31, 2019.
Performance
PMVP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PMVP Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.6% | -17.5% |
3 y3 years | -182.1% | -17.5% |
5 y5 years | -518.9% | -17.5% |
PMVP Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -84.8% | at low | -106.1% | at low |
5 y | 5-year | -310.9% | at low | -358.3% | at low |
alltime | all time | -518.9% | at low | -358.3% | at low |
PMV Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$345.71 M(+5.9%) |
Jun 2024 | - | -$326.49 M(+0.4%) |
Mar 2024 | - | -$325.27 M(+4.9%) |
Dec 2023 | -$310.00 M(+28.6%) | -$310.00 M(+5.4%) |
Sep 2023 | - | -$294.25 M(+6.0%) |
Jun 2023 | - | -$277.61 M(+6.7%) |
Mar 2023 | - | -$260.17 M(+7.9%) |
Dec 2022 | -$241.04 M | -$241.04 M(+8.7%) |
Sep 2022 | - | -$221.70 M(+9.0%) |
Jun 2022 | - | -$203.47 M(+9.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$186.16 M(+11.0%) |
Dec 2021 | -$167.73 M(+52.6%) | -$167.73 M(+12.3%) |
Sep 2021 | - | -$149.37 M(+11.2%) |
Jun 2021 | - | -$134.36 M(+10.6%) |
Mar 2021 | - | -$121.48 M(+10.6%) |
Dec 2020 | -$109.88 M(+45.7%) | -$109.88 M(+10.5%) |
Sep 2020 | - | -$99.43 M(+9.7%) |
Jun 2020 | - | -$90.66 M(+20.2%) |
Dec 2019 | -$75.44 M(+50.6%) | -$75.44 M |
Dec 2018 | -$50.09 M | - |
FAQ
- What is PMV Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual retained earnings year-on-year change?
- What is PMV Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly retained earnings year-on-year change?
What is PMV Pharmaceuticals annual retained earnings?
The current annual retained earnings of PMVP is -$310.00 M
What is the all time high annual retained earnings for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual retained earnings is -$50.09 M
What is PMV Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, PMVP annual retained earnings has changed by -$68.96 M (-28.61%)
What is PMV Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of PMVP is -$345.71 M
What is the all time high quarterly retained earnings for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly retained earnings is -$75.44 M
What is PMV Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, PMVP quarterly retained earnings has changed by -$51.47 M (-17.49%)